FIELD: pharmaceuticals.
SUBSTANCE: invention relates to the field of medicine and discloses a pharmaceutical composition with antiarrhythmic activity of various etiologies, containing acetamide 2-(diethylamino)-N-(2,6-dimethylphenyl) L-glutamate, (2R,3R)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-2,3-dihydrochromene-4-one (dihydroquercetin), and excipients: corn starch, kollidon VA 64, mannitol, microcrystalline cellulose, magnesium sulphate, magnesium stearate, colloidal silicon dioxide (aerosil).
EFFECT: lower toxicity on oral/sublingual administration and higher effectiveness in preventing early occlusive and reperfusion arrhythmias.
2 cl, 6 tbl, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| 2-(DIETHYLAMINO)-N-(2,6-DIMETHYLPHENYL)ACETAMIDE L-GLUTAMATE, HAVING PROLONGED ANTIARRHYTHMIC ACTIVITY, PHARMACEUTICAL COMPOSITION | 2018 |
|
RU2697717C1 |
| PHARMACEUTICAL COMPOSITION POSSESSING PROLONGED ANTIARRHYTHMIC ACTIVITY | 2012 |
|
RU2538674C2 |
| 2-AMINOCHROMEN DERIVATIVES EXHIBITING ANTI-TUMOR ACTIVITY; PHARMACEUTICAL COMPOSITIONS | 2018 |
|
RU2704262C1 |
| ANTI-ISCHEMIC REMEDY POSSESSING ANTI-ARRHYTHMIC AND ANTI-ATHEROGENIC ACTIVITY AND METHOD FOR APPLYING THE MEANS | 2004 |
|
RU2259822C1 |
| APPLICATION OF GLUTARIC ACID DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS AS ANTIARRHYTHMIC DRUG | 2008 |
|
RU2373934C1 |
| AGENT POSSESSING ANTIARRHYTHMIC ACTION | 2019 |
|
RU2700263C1 |
| METHOD OF PRODUCING A 2,6-DIMETHYLPHENYLACETAMIDE DERIVATIVE HAVING CEREBROPROTECTIVE ACTIVITY | 2018 |
|
RU2690506C1 |
| ANTI-ARRHYTHMIC PREPARATION | 2002 |
|
RU2223759C1 |
| METHOD OF PREVENTION OF HEART RHYTHM DISORDER | 2007 |
|
RU2348408C1 |
| AGENT FOR TREATMENT OF PATIENTS WITH CARDIOVASCULAR DISEASES | 1999 |
|
RU2168989C1 |
